Silverarc Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Silverarc Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$379K	–	89
2021 Q3	$379K	Sell	50,000 -44,539	-47%	-$285K	0.21%	74
2021 Q2	$705	Sell	94,539 -5,461	-5%	-$42.1K	0.31%	72
2021 Q1	$780K	Sell	100,000 -30,000	-23%	-$300K	0.43%	60
2020 Q4	$1.2M	Buy	+130,000	New	+$1.13M	0.7%	46

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Silverarc Capital Management's SURF Position: Q4 2021 in Review

Silverarc Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2021, closing a stake of 50,000 shares — an estimated $379K sold.

Silverarc Capital Management first reported a position in SURF in Q4 2020 and held it in 4 quarters. The position peaked at $1.2M in Q4 2020. 106 funds tracked by Wall St. Rank hold SURF as of Q4 2021.

Silverarc Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Silverarc Capital Management sold 50,000 Surface Oncology, Inc. Common Stock shares in Q4 2021, an estimated $379K.
Silverarc Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Silverarc Capital Management's Surface Oncology, Inc. Common Stock position peaked at $1.2M in Q4 2020.
106 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2021.

Based on Silverarc Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.